Hope Discovered Here®
Creating a world without heart and vascular disease
We are the Minneapolis Heart Institute Foundation® (MHIF).
For more than 37 years, we’ve been a world-class cardiovascular research and education organization committed to making the impossible possible for our patients.
Patients are at the heart of our mission. We provide:
•Hope for patients, improving their well-being and life expectancy
•Hope for their children, siblings, parents and families
•Hope for new treatment options
•Hope for a world without heart and vascular disease
Benefits of Participating in Research
Every year, exciting breakthroughs and new discoveries stem from our research. These important findings advance medical knowledge, improving the health and lives of millions of people worldwide.
Be More Active
Potential to Unlock More Options
Make a Contribution
Find Clinical Research Trials
Read Our Latest News
During Heart Month in February, Dr. Peter Eckman joined host Lester Schuft on the KDUZ Radio Heart Show program in Hutchinson, Minn., to talk all about heart health.
Please join us for On the Pulse, a series of online cardiovascular updates from physician leaders in research and care at Minneapolis Heart Institute Foundation and the Minneapolis Heart Institute® addressing latest advancements and current challenges.
Long-time friend, patient and supporter Ruth Stricker Dayton passed away on Tuesday, April 14. Ruth’s philanthropic impact is felt throughout many other organizations in Minnesota and the world.
Join Us at Upcoming Events
Gather your favorite women and join us for an evening of Hope, Health & Humor.
THANK YOU Another successful MHIF Founder’s Event at the Minikahda Club! A night spent reminiscing and celebrating the history, growth, accomplishments, and continued mission of innovative research and education at the Minneapolis Heart...
Agenda: 5:00-6:00PM Registration, dinner & exhibits 6:00-6:10PM Welcome – David Hurrell, MD 6:10-6:30PM The Role of PCSK9 Inhibitors & Clinical Update - Thomas Knickelbine, MD 6:30-6:50PM Incorporating PCSK9 Inhibitors into a Risk-based Approach...